Table 4.
Cancer Genes with Mutations in Primary Tumor and Lymph Node Samples.
| Pathway | P Value | Genes |
| Genes Mutated in Primary Tumor Samples Only | ||
| Notch signaling | .011 | MAML2 |
| Transcriptional regulatory network in embryonic stem cells | .012 | MYST3 |
| Regulation of IL-2 expression in T lymphocytes | .024 | BCL10 |
| HMGB1 signaling | .028 | MYST3 |
| T cell receptor signaling | .029 | BCL10 |
| Cluster of differentiation 28 signaling in T helper cells | .034 | BCL10 |
| Protein kinase C θ signaling in T lymphocytes | .034 | BCL10 |
| Phosphoinositide 3-kinase signaling in B lymphocytes | .038 | BCL10 |
| B cell receptor signaling | .047 | BCL10 |
| Nuclear factor kappa-light-chain-enhancer of activated B cells signaling | .049 | BCL10 |
| Genes Mutated in Lymph Node Samples Only | ||
| Transcriptional regulatory network in embryonic stem cells | .009 | TRIM24 |
| PDGF signaling | .018 | ABL2 |
| Ras homolog gene family, member A signaling | .028 | ABL2 |
| Retinoic acid receptor activation | .041 | TRIM24 |